Which specialist diagnoses and treats Ehlers‑Danlos syndrome?

Which Specialist Diagnoses and Treats Ehlers-Danlos Syndrome

Medical geneticists are the primary specialists who diagnose and classify Ehlers-Danlos syndrome, as they possess the expertise to evaluate inherited connective tissue disorders, coordinate appropriate genetic testing, and provide genetic counseling for all suspected cases. 1, 2, 3

Initial Screening and Referral Pathway

Primary Care and Subspecialty Screening

• Primary care clinicians should screen using the Beighton score (≥5/9 for adults <50 years, ≥4/9 for adults ≥50 years, ≥6/9 for prepubertal children) when patients present with chronic joint pain, recurrent dislocations, or multisystem symptoms. 2

• Gastroenterologists should actively screen for hypermobile EDS in patients with functional gastrointestinal disorders, since approximately 98% of hypermobile EDS patients experience GI manifestations. 1, 2

• Rheumatologists often conduct the initial joint hypermobility assessment using the Beighton scale and evaluate musculoskeletal manifestations before referring to genetics. 2, 3

When to Refer to Medical Genetics

• Refer immediately when clinical features suggest EDS, family history shows autosomal dominant inheritance, or arteriopathy is suspected. 3

• Genetic counseling is paramount before mutation screening due to complex financial, insurance, familial, and social implications. 1

Subtype-Specific Specialist Involvement

Vascular EDS (Type IV) – A Medical Emergency

• Urgent COL3A1 genetic testing must be ordered by medical geneticists when vascular EDS is suspected, as this is a life-threatening subtype with median survival of 48-51 years. 1, 3

• After molecular diagnosis, vascular surgeons and cardiologists become the central providers for ongoing surveillance and management due to high risk of arterial rupture and aneurysm. 1, 3

• Vascular surgery coordinates non-invasive surveillance imaging protocols (Doppler ultrasound, CT, or MRI) from head to pelvis, with annual follow-up imaging to detect new arterial dilatation or dissection. 1, 3

• Critical pitfall: Invasive vascular imaging or arteriography must be avoided in vascular EDS patients, as fatal complications have been reported. 1, 3

Hypermobile EDS (80-90% of Cases)

Hypermobile EDS has no available genetic test and requires clinical diagnosis using the 2017 criteria, making the multidisciplinary clinical assessment essential. 2, 3

Core Specialists in hEDS Management

• Rheumatologists assess joint hypermobility using the Beighton scale and manage musculoskeletal complications. 2, 3

• Gastroenterologists manage GI symptoms (nausea, abdominal pain, constipation, bloating, reflux) affecting nearly all hEDS patients, and should perform early celiac disease testing. 1, 2

• Cardiologists screen for aortic root dilation (present in 25-33% of hEDS patients) with baseline echocardiogram, then annually if normal or every 6 months if diameter exceeds 4.5 cm. 1, 2

• Neurologists and autonomic specialists evaluate for postural orthostatic tachycardia syndrome (POTS), affecting up to 37.5% of hEDS patients, diagnosed by heart rate increase ≥30 beats/min within 10 minutes of standing without orthostatic hypotension. 1, 2

• Allergy/mast cell specialists assess for mast cell activation syndrome (MCAS) only when patients exhibit episodic multisystem symptoms (flushing, urticaria, wheezing); baseline serum tryptase should be obtained only in these specific cases, not routinely. 1, 2

Essential Supportive Specialists

• Physical medicine and rehabilitation specialists prescribe low-resistance exercise programs to increase muscle tone and improve joint stability, forming the cornerstone of hEDS treatment. 2

• Pain management specialists coordinate non-opioid pain strategies; opioid use should be avoided, especially in patients with gastrointestinal involvement. 2

• Clinical psychologists and liaison psychiatrists address the high prevalence of psychological distress in EDS patients. 1, 2

• Ophthalmologists perform dilated eye examinations to rule out Marfan syndrome and related connective tissue disorders. 1

• Obstetricians provide high-risk pregnancy care for women with EDS, given increased risk of uterine and arterial rupture, particularly in vascular EDS. 1, 2

Critical Diagnostic Pitfalls

• Do not confirm an hEDS diagnosis without first using genetic testing to exclude alternative hereditary conditions, as approximately 26.4% of individuals initially diagnosed with hEDS are later found to have alternative genetic conditions requiring different management. 3, 4

• Failure to recognize vascular EDS carries significant mortality risk from arterial or organ rupture; any suspicion warrants urgent genetic testing. 1

• Rheumatologists and gastroenterologists may apply the clinical diagnostic criteria for hEDS before referring to genetics, helping to reduce unnecessary genetic counselor workload while ensuring appropriate screening. 3, 5

Ongoing Multidisciplinary Coordination

After the initial genetic diagnosis by medical geneticists, a multidisciplinary team—including cardiology, gastroenterology, physical medicine & rehabilitation, and genetics specialists—should provide ongoing management to address the multisystem nature of EDS. 2, 3 Coordinated care is essential because EDS involves multiple organ systems, requiring integrated surveillance and treatment strategies tailored to the specific complications of each subtype. 3